China to speed up 'new productive forces', Vice President saysVice President Han Zheng emphasizes innovation in advanced sectors and market-oriented, law-based environment to attract foreign firms, ens...
Pfizer will spend $43 billion to acquire Seagen"Together, Pfizer and Seagen seek to accelerate the next generation of cancer breakthroughs and bring new solutions to patients by combinin...
Pfizer buys Seagen for $43B, boosts access to cancer drugsThe deal announced Monday will combine Seagen's technology with Pfizer's scale and strength, Pfizer CEO Albert Bourla said in a statement. ...
Pfizer to acquire Biohaven by early 2023 for $11.6 billionBiohaven Pharmaceutical Holding Company Ltd. and Pfizer Inc. announced that both the companies have entered into an agreement wherein Pfize...
Pfizer-BioNTech begin Omicron vaccine trialPfizer's CEO Albert Bourla has previously said that the pharmaceutical giant could be ready to file for regulatory approval of the shot by ...
Pfizer-BioNTech to get EU 200 million more COVID-19 shotsThe U.S. and German companies said in a statement that the doses come on top of the 300 million vaccine doses the bloc has initially ordere...
WHO says deal with Pfizer to allow poor countries to start vaccinating in FebruaryThe COVAX programme has signed deals for hundreds of millions of doses to vaccinate people in poor and lower-middle income countries, but h...
UK vaccine approval 'historic moment' in Covid-19 battle: Pfizer CEO"Today's Emergency Use Authorisation in the UK marks a historic moment in the fight against Covid-19," said Pfizer CEO Albert Bourla.
Pfizer not yet ready to release COVID-19 vaccine data from late-stage trialPharma major Pfizer Inc said the company could release data on whether or not the vaccine works as early as this month.
Mylan deal to give a boost to Pfizerās India business: AnalystsOn Monday, Pfizer and Mylan announced that as per the Reverse Morris Trust transaction, each Mylan share would be converted into one share ...
GSK-Pfizer combo likely to be booster dose for brands in IndiaGSK and Pfizer said on Wednesday they will merge their consumer healthcare businesses, which have combined sales of $12 billion, by creatin...
Pfizer replaces longtime CEO Read with veteran BourlaRead, who was appointed CEO in December 2010, will become the executive chairman of Pfizer's board from Jan. 1.
Buy Pfizer with a target of Rs 168: Sandeep WaglePfizer Ltd is a 'BUY' call with a target of Rs 1915 and a stop loss of Rs 1757.
- Buy Pfizer Ltd with target price of Rs 1540: Sandeep Wagle
"Pfizer Ltd is a 'BUY' call with a target of Rs 1540 and a stop loss of Rs 1350."
- Buy Pfizer with a target of Rs 1430: Sandeep Wagle
Pfizer is a 'BUY' call with a target of Rs 1430 and a stop loss of Rs 1330.
- Read succeeds Kindler as Pfizer CEO
Ian C Read has been appointed as President and Chief Executive Officer (CEO) of Pfizer Inc, the US-based drug maker, succeeding Jeffrey B K...
- Pfizer to continue recruitment drive
Pfizer India will hire an additional 200 people in the next few months and will continue to increase its headcount because it sees minimal ...